Literature DB >> 15243577

The vital osteoclast: how is it regulated?

D Aeschlimann, B A J Evans.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15243577     DOI: 10.1038/sj.cdd.4401470

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  6 in total

1.  Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  X Yuan; J Cao; T Liu; Y-P Li; F Scannapieco; X He; M J Oursler; X Zhang; J Vacher; C Li; D Olson; S Yang
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

2.  Central giant cell lesion.

Authors:  James C Valentine; Brenda L Nelson
Journal:  Head Neck Pathol       Date:  2011-09-04

3.  Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions.

Authors:  Ying-Xiao Fu; Jian-Hong Gu; Yi-Ran Zhang; Xi-Shuai Tong; Hong-Yan Zhao; Yan Yuan; Xue-Zhong Liu; Jian-Chun Bian; Zong-Ping Liu
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

4.  Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.

Authors:  Li Lu; Li Rao; Huanhuan Jia; Jun Chen; Xingyan Lu; Guozhu Yang; Qingnan Li; Kenneth Ka Ho Lee; Li Yang
Journal:  J Cell Mol Med       Date:  2017-02-03       Impact factor: 5.310

5.  Effects of 9cis,11trans and 10trans,12cis CLA on osteoclast formation and activity from human CD14+ monocytes.

Authors:  Ilana Platt; Ahmed El-Sohemy
Journal:  Lipids Health Dis       Date:  2009-04-29       Impact factor: 3.876

Review 6.  The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.

Authors:  Sathana Dushyanthen; Davina A F Cossigny; Gerald M Y Quan
Journal:  Cancer Growth Metastasis       Date:  2013-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.